세계의 FISH(Fluorescence In Situ Hybridization) 프로브 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2032년)

The global demand for Fluorescence In Situ Hybridization Probe Market is presumed to reach the market size of nearly USD 1004.75 Million by 2032 from USD 878.75 Million in 2023 with a CAGR of 1.5% under the study period 2024-2032.

Fluorescence in situ hybridization (FISH) probes are molecular tools that detect and localize specific DNA sequences within chromosomes. These probes are labeled with fluorescent dyes and hybridize to their complementary DNA sequences in the sample. When viewed under a fluorescence microscope, the probes emit light, revealing the presence and location of the target genetic material. FISH probes are widely used in genetic research, clinical diagnostics, and cancer studies to identify chromosomal abnormalities, gene fusions, and copy number variations. This technique provides high-resolution insights into the genetic makeup of cells, aiding in diagnosis and guiding treatment strategies.

MARKET DYNAMICS

The surging prevalence of genetic disorders, infectious diseases, and cancer drives demand for molecular diagnostic tests that utilize FISH probes to detect chromosomal aberrations, gene mutations, and pathogenic microorganisms with high specificity and sensitivity. This growing disease burden underscores the importance of accurate and reliable genetic testing methods in clinical practice, fuelling market demand for fluorescence in situ hybridization probes. Advancements in probe design, fluorophore chemistry, and imaging technologies have led to the development of innovative FISH probe assays that offer enhanced signal-to-noise ratios, multiplexing capabilities, and automation features, enabling researchers and clinicians to perform complex genomic analyses with greater efficiency and precision. Additionally, expanding applications of FISH probes in research, drug discovery, and personalized medicine drive market expansion by enabling the study of gene expression patterns, DNA replication dynamics, and spatial organization of chromosomes in diverse biological samples and disease models.

Moreover, the increasing adoption of companion diagnostics and targeted therapy approaches in oncology and infectious diseases augment market demand for fluorescence in situ hybridization probes as companion diagnostic tools for patient stratification, treatment selection, and disease monitoring. Furthermore, supportive regulatory frameworks and reimbursement policies for molecular diagnostics and personalized medicine drive market growth by ensuring product quality, safety, and reimbursement coverage. However, the high cost of probes and the need for specialized equipment may challenge the fluorescence in situ hybridization probe market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Fluorescence In Situ Hybridization Probe. The growth and trends of Fluorescence In Situ Hybridization Probe industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Fluorescence In Situ Hybridization Probe market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• DNA
• RNA (mRNA, miRNA, Other)

By Technology

• Q FISH
• FLOW FISH
• Others

By Application

• Cancer Research (Lung, Breast, Bladder, Blood, Prostrate, Cervical, Others)
• Genetic Diseases
• Others

By End User

• Research & Academic Institutes
• Diagnostic Centers
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Fluorescence In Situ Hybridization Probe market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Fluorescence In Situ Hybridization Probe market include Genemed Biotechnologies Inc., PerkinElmer Inc., F. Hoffmann-La Roche AG, Abnova Corporation, Oxford Gene Technologies, Life Science Technologies, Biosearch Technologies Inc., Biocare Medical LLC, Abbott Laboratories, Agilent Technologies. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. FLUORESCENCE IN SITU HYBRIDIZATION PROBE - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Technology
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By End User
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET ANALYSIS BY TYPE

• 5.1. Overview By Type
• 5.2. Historical and Forecast Data Analysis By Type
• 5.3. DNA Historic and Forecast Sales By Regions
• 5.4. RNA (mRNA, miRNA, Other) Historic and Forecast Sales By Regions

6. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET ANALYSIS BY TECHNOLOGY

• 6.1. Overview By Technology
• 6.2. Historical and Forecast Data Analysis By Technology
• 6.3. Q FISH Historic and Forecast Sales By Regions
• 6.4. FLOW FISH Historic and Forecast Sales By Regions
• 6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET ANALYSIS BY APPLICATION

• 7.1. Overview By Application
• 7.2. Historical and Forecast Data Analysis By Application
• 7.3. Cancer Research (Lung, Breast, Bladder, Blood, Prostrate, Cervical, Others) Historic and Forecast Sales By Regions
• 7.4. Genetic Diseases Historic and Forecast Sales By Regions
• 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET ANALYSIS BY END USER

• 8.1. Overview By End User
• 8.2. Historical and Forecast Data Analysis By End User
• 8.3. Research & Academic Institutes Historic and Forecast Sales By Regions
• 8.4. Diagnostic Centers Historic and Forecast Sales By Regions
• 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE FLUORESCENCE IN SITU HYBRIDIZATION PROBE COMPANIES

• 10.1. Fluorescence In Situ Hybridization Probe Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF FLUORESCENCE IN SITU HYBRIDIZATION PROBE INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Genemed Biotechnologies Inc.
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. PerkinElmer Inc.
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. F. Hoffmann-La Roche AG
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Abnova Corporation
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Oxford Gene Technologies
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Life Science Technologies
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Biosearch Technologies Inc.
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Biocare Medical LLC
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Abbott Laboratories
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Agilent Technologies
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies